FOXD1-AS1, upregulated in malignancies, correlates with poor prognosis and enhances HCC immune evasion by increasing PD-L1 as a ceRNA for miR-615-3p. It also regulates CTC EMT via PI3K/AKT signaling. This evidence concerns the gene AKT1 and hepatocellular carcinoma.